Signet Announces the Appointment of M. Thomas Boyer as Consultant for the Revolutionary New Medical Device to Prevent Amputations, the ConnREAP™
Signet International Holdings, Inc. (OTC:SIGN) subsidiary, Signet Medical Solutions, Inc., announced the appointment of M. Thomas Boyer, V/P, long-time health care entrepreneur. Mr. Boyer will perform a consulting role in the advancement of the ConnREAP™, the revolutionary new medical device that prevents amputations. - February 28, 2019
Signet Announces the Appointment of Bradley Nelson, Chief Engineer of Project, "deIce 477"
Nelson, V/P of subsidiary Signet Graphene Technologies, Inc., will assume a liaison role in the development of the new graphene-based deicing project in connection with Florida International University (FIU). - February 15, 2019
Signet Announces Acquisition of a New Medical Device to Prevent Amputations
New medical device, named the ConnREAP™, will enable physicians - for the first time - to gain optimal access to leg arteries to restore blood flow and prevent amputations. - January 25, 2019
Graphene Technology to Deice Aircraft Enters $1.30 Billion Deicing Market, Time Saving, More Efficient & Less Toxic
Signet International Holdings, Inc.’s (OTC: SIGN) subsidiary, SGT, has executed a contract with Florida International University (FIU) to further the development and commercialization of a new deicing technology enhanced by graphene, the revolutionary carbon-based nanotechnology. The graphene foam−polymer composite has superior deicing efficiency and strength, and is expected to have a major impact on the aircraft deicing market. - January 17, 2019